[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2973 Introduced in House (IH)]

<DOC>






115th CONGRESS
  1st Session
                                H. R. 2973

    To provide for the issuance of an Alzheimer's Disease Research 
                           Semipostal Stamp.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 21, 2017

Ms. Maxine Waters of California (for herself, Mr. Smith of New Jersey, 
 Mr. Garamendi, Mr. Grijalva, Mr. Conyers, Ms. Ros-Lehtinen, Mr. Young 
 of Alaska, Mr. Cole, Mr. Lamborn, Mr. Evans, Ms. Clarke of New York, 
Mr. DeFazio, Mr. Hastings, Ms. Jackson Lee, Ms. Wilson of Florida, Ms. 
Hanabusa, Ms. Norton, Ms. Matsui, Mrs. Napolitano, Mrs. Watson Coleman, 
 Mr. Keating, Mr. Higgins of New York, Ms. Barragan, Mr. Sean Patrick 
Maloney of New York, Mr. Payne, Ms. Lee, Mr. Norcross, Mr. Raskin, Mr. 
 Delaney, Ms. Moore, Mr. Cohen, Mr. Johnson of Georgia, Ms. Plaskett, 
 Mr. Tonko, Ms. Sanchez, Mr. David Scott of Georgia, Mrs. Dingell, Mr. 
Sires, Ms. Kaptur, Ms. Wasserman Schultz, Ms. Roybal-Allard, Mr. Soto, 
 Ms. Shea-Porter, Mr. Lewis of Georgia, Mr. Ellison, Mrs. Beatty, Ms. 
 Kuster of New Hampshire, Ms. Lofgren, Mr. Serrano, Mr. Peterson, Ms. 
DelBene, Mr. Lipinski, Mr. Brown of Maryland, Mr. Suozzi, Ms. Michelle 
Lujan Grisham of New Mexico, Mr. Blum, Mr. Barletta, Mr. McGovern, Mr. 
 Schneider, Mr. King of New York, Ms. Clark of Massachusetts, and Mr. 
  Costello of Pennsylvania) introduced the following bill; which was 
 referred to the Committee on Oversight and Government Reform, and in 
 addition to the Committee on Energy and Commerce, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
    To provide for the issuance of an Alzheimer's Disease Research 
                           Semipostal Stamp.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ALZHEIMER'S DISEASE RESEARCH SEMIPOSTAL STAMP.

    (a) In General.--In order to afford a convenient way for members of 
the public to contribute to funding for medical research relating to 
Alzheimer's disease, the United States Postal Service shall issue a 
semipostal stamp (referred to in this Act as the ``Alzheimer's Disease 
Research Semipostal Stamp'') in accordance with the provisions of this 
section.
    (b) Terms and Conditions.--
            (1) In general.--The issuance and sale of the Alzheimer's 
        Disease Research Semipostal Stamp shall be governed by the 
        provisions of section 416 of title 39, United States Code, and 
        regulations issued under such section, subject to the 
        requirements of this subsection.
            (2) Duration.--The Alzheimer's Disease Research Semipostal 
        Stamp shall be made available to the public for a period of 6 
        years, beginning no later than 12 months after the date of the 
        enactment of this Act.
            (3) Disposition of proceeds.--All amounts becoming 
        available from the sale of the Alzheimer's Disease Research 
        Semipostal Stamp (as determined under section 416(d) of such 
        title 39) shall be transferred to the National Institutes of 
        Health, for the purpose described in subsection (a), through 
        payments which shall be made at least twice a year.
    (c) Definition.--For purposes of this Act, the term ``semipostal 
stamp'' refers to a stamp described in section 416(a)(1) of title 39, 
United States Code.
                                 <all>